Fleming Laboratories Limited

Fleming Laboratories Limited - pharma in Telangana, India. FY 2026 financials & compliance.
CIN U24230TG1992PLC014560 Incorporated 23 July 1992 ROC Hyderabad HQ Telangana, India
Active Public Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹135.89 Cr
▲ 14% YoY
Net profit · FY 2025
₹16.04 Cr
Net margin 11.8%
EBITDA · FY 2025
₹31.23 Cr
EBITDA margin 23%
Authorised capital
₹45 Cr
Registered with MCA
Paid-up capital
₹44.02 Cr
Issued & subscribed
Open charges
₹62.62 Cr
Satisfied ₹34.23 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
271
Provident fund records

About Fleming Laboratories Limited

Data last updated:

Fleming Laboratories Limited is a public limited company based in Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 July 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1992PLC014560. Its GSTIN is 36AAACF3245M1ZK (Telangana). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹44.02 Cr. It is led by directors including Jeyamuruga Prakash Manoharan (Managing Director) and Kesavamuralidhar Vadakattu.

Its last annual general meeting (AGM) was held on 24 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No. 270 275 276 353 & 354 Navabpet Village, Telangana, India – 502313.

As per the financials filed for FY 2025, the company reported a revenue of ₹135.89 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹16.04 Cr (net margin 11.8%) and EBITDA of ₹31.23 Cr (EBITDA margin 23%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.

The company has about 271 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Fleming Laboratories. As per MCA filings, the company has open charges of ₹62.62 Cr and satisfied charges of ₹34.23 Cr on record. Court records list 33 cases involving the company, including 14 filed by the company and 21 filed against it; 6 cases are pending. The company has 11 deals on record (8 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.5 Cr; the latest was in March 2024.

Fleming Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-06-0000074). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fleminglabs.com.

Company details

CIN U24230TG1992PLC014560
Registration Number 014560
Incorporation Date 23 July 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-06-0000074

CIN history

Fleming Laboratories has one previous CIN (Corporate Identification Number): U24230AP1992PLC014560. The current CIN is U24230TG1992PLC014560, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG1992PLC014560Current
U24230AP1992PLC014560Previous

Recognitions & Rankings of Fleming Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-06-0000074

Contact details

Fleming Laboratories Limited's registered office is in Telangana. Its website is fleminglabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Survey No. 270 275 276 353 & 354 Navabpet Village, Telangana, India – 502313
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Fleming Laboratories Limited, buy the company report.

Comprehensive company report
Fleming Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Fleming Laboratories operates one associated brand: Fleming Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Niche and off-beat APIs are developed, manufactured, and exported.fleminglabs.com

Business activity

The main business activity of Fleming Laboratories is manufacturing. In detail, this covers computer, electronic, communication and scientific measuring & control equipment.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC9Computer, electronic, Communication and scientific measuring & control equipment

To see the full business activity and turnover split of Fleming Laboratories Limited, buy the company report.

Financials of Fleming Laboratories Limited

FY 2025 filings available

Fleming Laboratories Limited reported revenue of ₹135.89 Cr (up 14% YoY) for FY 2025.

Revenue · FY 2025
₹135.89 Cr ▲ 14%
Net profit · FY 2025
₹16.04 Cr margin 11.8%
EBITDA · FY 2025
₹31.23 Cr margin 23%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 1%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 98%
3 years · compounded
▼ 4%
5 years · compounded
▲ 7%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 14% growth in the latest year. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹31.23 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16.04 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin23%
Net Profit Margin11.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Fleming Laboratories Limited, buy the company report.

Board of directors of Fleming Laboratories Limited

Fleming Laboratories has 5 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
NithyagovindNominee Director15 Dec 20232 Years 10 MonthsCurrent
Kesavamuralidhar VadakattuDirector25 Oct 20197 Years 0 MonthsCurrent
Shivakumar BalakrishnanDirector23 Aug 20233 Years 2 MonthsCurrent
Jeyamuruga Prakash ManoharanManaging Director20 Nov 201411 Years 11 MonthsCurrent
Nadar Mariappa VeluchamyDirector11 Aug 201610 Years 2 MonthsCurrent

Auditor

Fleming Laboratories Limited is audited by LNP & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
LNP & CoFY 2023008918S

Shareholding

The shareholding of Fleming Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Fleming Laboratories Limited, buy the company report.

Charges & borrowings

Open charges
₹62.62 Cr
Satisfied charges
₹34.23 Cr
Breakdown by lending institutions
Others₹42.62 Cr
Hdfc Bank Limited₹20.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jan 2026101231200Others₹99 LakhOpen
10 Oct 2025101167804Others₹2.1 CrOpen
26 Sep 2022100617371Hdfc Bank Limited₹20 CrOpen
10 Feb 2021100414272Others₹3.03 CrOpen
29 Sep 2020100377944Others₹36.5 CrOpen

To see the full charge records of Fleming Laboratories Limited, buy the company report.

Total charge records: 13 View all charges

Deals & funding

Fleming Laboratories Limited has 11 deals on record (8 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.5 Cr; the latest was in March 2024.

Total deals
11
Secondary share transfers
8
Funding rounds
3
Disclosed funding
₹42.5 Cr

Deals on record (5 of 11)

WhenDealAmountParties
Mar 2024Secondary share transferUndisclosedBuyer: InvAscent, 3 individuals
Seller: 4 individuals
Dec 2023Funding round₹25 CrInvestors: InvAscent
Nov 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Dec 2014Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Sep 2014Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals

To see the full deal history of Fleming Laboratories Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Fleming Laboratories Limited was last rated by Care on 05 Oct 2021.

Rating agencyRated onRating
Care05 Oct 2021

To see the full credit ratings and regulatory alerts of Fleming Laboratories Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Fleming Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Fleming Laboratories has 1 joint venture and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Joint ventures
1
Associated companies

Employees & EPFO

Fleming Laboratories Limited has a workforce of 271 employees on its EPFO records as of Aug 06, 2024, across 1 active EPFO establishment.

Employee count
271
Active EPFO establishments
1
Employee growth
4.23%

GST

Fleming Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AAACF3245M1ZKTelanganaActive01 Jul 2017
29AAACF3245M1ZFKarnatakaActive01 Jan 2022

To see the full GST registrations and return filing status of Fleming Laboratories Limited, buy the company report.

Recent activity

Fleming Laboratories Limited has 22 board changes on record since 2007: 6 appointments and 16 cessations. The latest: Niranjan Chittaranjan ceased to be CFO on 19 Nov 2024.

Charges
A charge with Others amounted to Rs. 0.99 Cr with Charge ID 101231200 was registered on 28 Jan 2026.
Charges
A charge with Hdfc Bank Limited of Rs. 20.00 Cr registered on 26 Sep 2022 with Charge ID 100617371 was modified on 10 Dec 2025.
AGM
Fleming Laboratories Limited last Annual general meeting of members was held on 24 Oct 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2.10 Cr with Charge ID 101167804 was registered on 10 Oct 2025.
Charges
A charge with Others of Rs. 36.50 Cr registered on 29 Sep 2020 with Charge ID 100377944 was modified on 30 Aug 2025.
Filing
Fleming Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Niranjan Chittaranjan ceased to be CFO.
Appointed
Navneet Kaur was appointed as Company Secretary.
Ceased
Chaitanya Madhukar Date ceased to be Company Secretary.
Appointed
Nithyagovind was appointed as Nominee Director.
Appointed
Shivakumar Balakrishnan was appointed as Director.
Charges
A charge registered on 05 Mar 2011 via Charge ID 10280574 with Sbi Global Factors Limited was fully satisfied on 28 Sep 2022.

39 earlier events are in the company report.

Frequently asked questions

Fleming Laboratories is an active public limited company based in Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 July 1992 (34+ years old) and is registered under CIN U24230TG1992PLC014560.

Fleming Laboratories has 5 current directors:

The latest financial statements of Fleming Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 October 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Fleming Laboratories is 36AAACF3245M1ZK, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAACF3245M1ZF (Karnataka).

The CIN (Corporate Identification Number) of Fleming Laboratories is U24230TG1992PLC014560. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Fleming Laboratories has 33 court cases on record: 14 filed by the company and 21 filed against it. 6 are pending. Most are in the district courts.

Fleming Laboratories was incorporated on 23 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.

Fleming Laboratories has 11 deals on record (8 secondary share transfers, 3 funding rounds), with disclosed funding of ₹42.5 Cr; the latest was in March 2024.

Niranjan Chittaranjan ceased to be CFO on 19 Nov 2024. Navneet Kaur was appointed as Company Secretary on 03 Feb 2024. Chaitanya Madhukar Date ceased to be Company Secretary on 31 Dec 2023. Fleming Laboratories has 22 board changes on record in total.

Yes, Fleming Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-06-0000074).